Literature DB >> 10818139

Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site.

J N Kew1, A Koester, J L Moreau, F Jenck, A M Ouagazzal, V Mutel, J G Richards, G Trube, G Fischer, A Montkowski, W Hundt, R K Reinscheid, M Pauly-Evers, J A Kemp, H Bluethmann.   

Abstract

We have used site-directed mutagenesis in conjunction with homologous recombination to generate two mouse lines carrying point mutations in the glycine binding site of the NMDAR1 subunit (Grin1). Glycine concentration-response curves from acutely dissociated hippocampal neurons revealed a 5- and 86-fold reduction in receptor glycine affinity in mice carrying Grin1(D481N) and Grin1(K483Q) mutations, respectively, whereas receptor glutamate affinity remained unaffected. Homozygous mutant Grin1(D481N) animals are viable and fertile and appear to develop normally. However, homozygous mutant Grin1(K483Q) animals are significantly lighter at birth, do not feed, and die within a few days. No gross abnormalities in CNS anatomy were detected in either Grin1(D481N) or Grin1(K483Q) mice. Interestingly, in situ hybridization and Western blot analysis revealed changes in the expression levels of NMDA receptor subunits in Grin1(D481N) mice relative to wild type that may represent a compensatory response to the reduction in receptor glycine affinity. Grin1(D481N) mice exhibited deficits in hippocampal theta burst-induced long-term potentiation (LTP) and spatial learning and also a reduction in sensitivity to NMDA-induced seizures relative to wild-type controls, consistent with a reduced activation of NMDA receptors. Mutant mice exhibited normal prepulse inhibition but showed increased startle reactivity. Preliminary analysis indicated that the mice exhibit a decreased natural aversion to an exposed environment. The lethal phenotype of Grin1(K483Q) animals confirms the critical role of NMDA receptor activation in neonatal survival. A milder reduction in receptor glycine affinity results in an impairment of LTP and spatial learning and alterations in anxiety-related behavior, providing further evidence for the role of NMDA receptor activation in these processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818139      PMCID: PMC6772652     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel.

Authors:  K Ikeda; M Nagasawa; H Mori; K Araki; K Sakimura; M Watanabe; Y Inoue; M Mishina
Journal:  FEBS Lett       Date:  1992-11-16       Impact factor: 4.124

2.  Role of N-methyl-D-aspartate receptors in the induction of synaptic potentiation by burst stimulation patterned after the hippocampal theta-rhythm.

Authors:  J Larson; G Lynch
Journal:  Brain Res       Date:  1988-02-16       Impact factor: 3.252

3.  Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor.

Authors:  J D Clements; G L Westbrook
Journal:  Neuron       Date:  1991-10       Impact factor: 17.173

Review 4.  The glycine site of the NMDA receptor--five years on.

Authors:  J A Kemp; P D Leeson
Journal:  Trends Pharmacol Sci       Date:  1993-01       Impact factor: 14.819

5.  Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.

Authors:  H Gu; Y R Zou; K Rajewsky
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

6.  Agonist response kinetics of N-methyl-D-aspartate receptors in neurons cultured from rat cerebral cortex and cerebellum: evidence for receptor heterogeneity.

Authors:  T Priestley; J A Kemp
Journal:  Mol Pharmacol       Date:  1993-12       Impact factor: 4.436

7.  Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death.

Authors:  D Forrest; M Yuzaki; H D Soares; L Ng; D C Luk; M Sheng; C L Stewart; J I Morgan; J A Connor; T Curran
Journal:  Neuron       Date:  1994-08       Impact factor: 17.173

8.  Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.

Authors:  K A Wafford; M Kathoria; C J Bain; G Marshall; B Le Bourdellès; J A Kemp; P J Whiting
Journal:  Mol Pharmacol       Date:  1995-02       Impact factor: 4.436

9.  Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.

Authors:  T Priestley; P Laughton; J Myers; B Le Bourdellés; J Kerby; P J Whiting
Journal:  Mol Pharmacol       Date:  1995-11       Impact factor: 4.436

10.  Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.

Authors:  M Hollmann; J Boulter; C Maron; L Beasley; J Sullivan; G Pecht; S Heinemann
Journal:  Neuron       Date:  1993-05       Impact factor: 17.173

View more
  26 in total

Review 1.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

2.  Calpain sensitive regions in the N-terminal cytoplasmic domains of glycine transporters GlyT1A and GlyT1B.

Authors:  Martina Baliova; Frantisek Jursky
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

3.  Repeated maternal glucocorticoid treatment affects activity and hippocampal NMDA receptor expression in juvenile guinea pigs.

Authors:  Dawn Owen; Stephen G Matthews
Journal:  J Physiol       Date:  2006-10-26       Impact factor: 5.182

4.  Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function.

Authors:  Michael A Benneyworth; Alo C Basu; Joseph T Coyle
Journal:  Psychopharmacology (Berl)       Date:  2010-09-24       Impact factor: 4.530

Review 5.  GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists.

Authors:  Joseph R Moskal; Ronald Burch; Jeffrey S Burgdorf; Roger A Kroes; Patric K Stanton; John F Disterhoft; J David Leander
Journal:  Expert Opin Investig Drugs       Date:  2013-11-20       Impact factor: 6.206

Review 6.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

7.  The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats.

Authors:  Jeffrey Burgdorf; Xiao-lei Zhang; Craig Weiss; Elizabeth Matthews; John F Disterhoft; Patric K Stanton; Joseph R Moskal
Journal:  Neurobiol Aging       Date:  2009-05-14       Impact factor: 4.673

8.  Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.

Authors:  Viviane Labrie; Tatiana Lipina; John C Roder
Journal:  Psychopharmacology (Berl)       Date:  2008-07-03       Impact factor: 4.530

9.  Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.

Authors:  V Labrie; W Wang; S W Barger; G B Baker; J C Roder
Journal:  Genes Brain Behav       Date:  2009-08-05       Impact factor: 3.449

10.  Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice.

Authors:  Suzanne A Brody; Mark A Geyer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.